75 related articles for article (PubMed ID: 10234576)
1. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects.
Obrant KJ; Käkönen SM; Astermark J; Lilja H; Lövgren T; Akesson K; Pettersson K
J Bone Miner Res; 1999 Apr; 14(4):555-60. PubMed ID: 10234576
[TBL] [Abstract][Full Text] [Related]
2. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats.
Haffa A; Krueger D; Bruner J; Engelke J; Gundberg C; Akhter M; Binkley N
J Bone Miner Res; 2000 May; 15(5):872-8. PubMed ID: 10804016
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability.
Hellman J; Käkönen SM; Matikainen MT; Karp M; Lövgren T; Väänänen HK; Pettersson K
J Bone Miner Res; 1996 Aug; 11(8):1165-75. PubMed ID: 8854253
[TBL] [Abstract][Full Text] [Related]
4. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin.
Luukinen H; Käkönen SM; Pettersson K; Koski K; Laippala P; Lövgren T; Kivelä SL; Väänänen HK
J Bone Miner Res; 2000 Dec; 15(12):2473-8. PubMed ID: 11127212
[TBL] [Abstract][Full Text] [Related]
5. A dual-label immunofluorometric assay for human osteocalcin.
Ylikoski A; Hellman J; Matikainen T; Käkönen SM; Karp M; Väänänen HK; Lövgren T; Pettersson K
J Bone Miner Res; 1998 Jul; 13(7):1183-90. PubMed ID: 9661083
[TBL] [Abstract][Full Text] [Related]
6. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
7. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women.
Plantalech L; Guillaumont M; Vergnaud P; Leclercq M; Delmas PD
J Bone Miner Res; 1991 Nov; 6(11):1211-6. PubMed ID: 1666807
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
[TBL] [Abstract][Full Text] [Related]
9. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc P; Chapuy MC; Meunier PJ; Delmas PD
J Clin Invest; 1993 Apr; 91(4):1769-74. PubMed ID: 8473517
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis.
Miki T; Nakatsuka K; Naka H; Kitatani K; Saito S; Masaki H; Tomiyoshi Y; Morii H; Nishizawa Y
J Bone Miner Metab; 2003; 21(3):161-5. PubMed ID: 12720050
[TBL] [Abstract][Full Text] [Related]
12. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
Akesson K; Käkönen SM; Josefsson PO; Karlsson MK; Obrant KJ; Pettersson K
J Bone Miner Metab; 2005; 23(1):30-5. PubMed ID: 15616891
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys.
Binkley N; Krueger D; Engelke J; Suttie J
J Bone Miner Res; 2007 May; 22(5):695-700. PubMed ID: 17295605
[TBL] [Abstract][Full Text] [Related]
14. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
17. Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GH-deficient adults.
Hubina E; Lakatos P; Kovács L; Szabolcs I; Rácz K; Tóth M; Szucs N; Góth MI
Calcif Tissue Int; 2004 Jan; 74(1):55-9. PubMed ID: 14508626
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.
Käkönen SM; Hellman J; Karp M; Laaksonen P; Obrant KJ; Väänänen HK; Lövgren T; Pettersson K
Clin Chem; 2000 Mar; 46(3):332-7. PubMed ID: 10702519
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of the predominant urine osteocalcin fragments detectable by two-site immunoassays.
Matikainen T; Käkönen SM; Pettersson K; Karp M; Lövgren T; Väänänen Hk; Hellman J
J Bone Miner Res; 1999 Mar; 14(3):431-8. PubMed ID: 10027908
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
